Christopher J. Tovey is COO at GW PHARMACEUTICALS PLC (GWPH). They have made 4 open-market trades across 2 companies since 2019, most recently 2022-07-05.
CIK 0001754163
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| JAZZ | SELL | 2022-07-05 | 2022-07-07 | $160.00 | $833K | +2.3% | -0.8% | -12.2% |
| GWPH | SELL | 2020-11-30 | 2020-12-02 | $11.69 | $2.6M | -10.7% | -15.1% | +58.3% |
| GWPH | SELL | 2019-06-03 | 2019-06-05 | $14.61 | $947K | -4.6% | -3.7% | -20.0% |
| GWPH | SELL · 10b5-1 | 2019-05-15 | 2019-05-17 | $15.01 | $18K | +1.3% | -2.2% | -12.2% |
| GWPH | SELL | 2019-05-07 | 2019-05-09 | $16.14 | $6.5M | +0.9% | -4.4% | -8.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.